Revision history of "Support of OncoArendi Therapeutics S.A. in access to the capital market through the purchase of advisory services in the scope of preparing documentation and carrying out analyses necessary to raise equity capital and debut of shares on the main market of" (Q82025)

13 October 2024

• curprev 06:0606:06, 13 October 2024‎ DG Regio talk contribs‎ 95,797 bytes +16‎ ‎Changed label, description and/or aliases in pt
• curprev 06:0606:06, 13 October 2024‎ DG Regio talk contribs‎ 95,781 bytes −47‎ ‎Set a claim value: summary (P836): Help_reference_reference number (Número de referência_ajuda): SA 42799(2015/X) Objetivo do auxílio público: Regulamento (UE) n.o 651/2014 Artigo 18.o Auxílios aos serviços de aconselhamento às PME A execução do projeto proposto permitirá à empresa inovadora de biotecnologia OncoArendi Therapeutics S.A. mobilizar eficazmente capitais privados junto de investidores institucionais e individuais no âmbito da emissão de ações e colocá-los no mercado públ...

20 March 2024

• curprev 13:4713:47, 20 March 2024‎ DG Regio talk contribs‎ 95,828 bytes +287‎ ‎Added qualifier: readability score (P590521): 0.247987719225545

12 January 2024

• curprev 16:4516:45, 12 January 2024‎ DG Regio talk contribs‎ 95,541 bytes +722‎ ‎Changed an Item

14 June 2023

• curprev 18:2718:27, 14 June 2023‎ Admin talk contribs‎ 94,819 bytes 0‎ BatchIngestion

11 June 2023

• curprev 11:1211:12, 11 June 2023‎ Admin talk contribs‎ 94,819 bytes +435‎ BatchIngestion

24 May 2023

• curprev 17:0317:03, 24 May 2023‎ DG Regio talk contribs‎ 94,384 bytes +949‎ ‎Changed an Item

2 March 2023

• curprev 23:0623:06, 2 March 2023‎ DG Regio talk contribs‎ 93,435 bytes +1,408‎ ‎Changed label, description and/or aliases in hr, lv, sl, pt, mt, fi, ga, el, da, cs, nl, es, lt, de, et, sk, it, ro, fr, bg, hu, sv, and other parts

27 October 2022

• curprev 23:1023:10, 27 October 2022‎ DG Regio talk contribs‎ 92,027 bytes +431‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

26 October 2022

• curprev 14:3214:32, 26 October 2022‎ DG Regio talk contribs‎ 91,596 bytes +866‎ ‎Changed an Item: Import item from Poland

21 October 2022

• curprev 11:2111:21, 21 October 2022‎ DG Regio talk contribs‎ 90,730 bytes +1,232‎ ‎Changed an Item: Import item from Poland
• curprev 11:2111:21, 21 October 2022‎ DG Regio talk contribs‎ 89,498 bytes −419‎ ‎Removed claim: co-financing rate (P837): 49.03 percentage

13 August 2022

• curprev 16:5016:50, 13 August 2022‎ DG Regio talk contribs‎ 89,917 bytes +58,750‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

19 January 2022

• curprev 12:1112:11, 19 January 2022‎ DG Regio talk contribs‎ 31,167 bytes +3,410‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 22:5422:54, 15 January 2022‎ DG Regio talk contribs‎ 27,757 bytes +3,254‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:5419:54, 16 December 2021‎ DG Regio talk contribs‎ 24,503 bytes +3,373‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 08:3808:38, 7 December 2021‎ DG Regio talk contribs‎ 21,130 bytes +3,321‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 14:3214:32, 30 November 2021‎ DG Regio talk contribs‎ 17,809 bytes +3,009‎ ‎Created claim: summary (P836): Numéro de référence_Aidprogam: SA 42799(2015/X) But_public_aid: Règlement (CE) no 651/2014 Article 18 Aide aux services de conseil en faveur des PME La mise en œuvre du projet proposé permettra à la société de biotechnologie innovante OncoArendi Therapeutics S.A. de mobiliser efficacement des capitaux privés auprès d’investisseurs institutionnels et individuels dans le cadre de l’émission d’actions et de leur commercialisation auprès du public s...
• curprev 14:3214:32, 30 November 2021‎ DG Regio talk contribs‎ 14,800 bytes +353‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 05:3305:33, 29 October 2020‎ DG Regio talk contribs‎ 14,447 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 05:3305:33, 29 October 2020‎ DG Regio talk contribs‎ 14,853 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 11:2711:27, 14 October 2020‎ DG Regio talk contribs‎ 14,887 bytes +334‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 11:2711:27, 14 October 2020‎ DG Regio talk contribs‎ 14,553 bytes −352‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 11:2711:27, 14 October 2020‎ DG Regio talk contribs‎ 14,905 bytes +2,749‎ ‎Created claim: summary (P836): Help_reference_reference number: SA 42799(2015/X) Purpose of public aid: EC Regulation No 651/2014 Article 18 Aid for advisory services for SMEs The implementation of the proposed project will enable the innovative biotechnology company OncoArendi Therapeutics S.A. to effectively raise private capital from institutional and individual investors in the framework of the issue of shares and to place them on the public market on the main market of t...
• curprev 11:2711:27, 14 October 2020‎ DG Regio talk contribs‎ 12,156 bytes −2,336‎ ‎Removed claim: summary (P836): Reference_reference_projet:SA 42799 (2015/X):Commission Regulation (EC) No 651/2014, Article 18 Aid for consultancy in favour of SMEs, Implementation of the proposed project will enable the innovative biotech company Oncolarendi Therapeutics S.A. to obtain private capital effectively from institutional and individual investors in the context of the issue and placing on the public market in the main market of Securities Exchanges (GPW).The acqu...

22 June 2020

• curprev 13:3813:38, 22 June 2020‎ DG Regio talk contribs‎ 14,492 bytes +1,581‎ ‎Changed an Item
• curprev 13:3813:38, 22 June 2020‎ DG Regio talk contribs‎ 12,911 bytes −1,581‎ ‎Removed claims

9 June 2020

• curprev 18:1018:10, 9 June 2020‎ DG Regio talk contribs‎ 14,492 bytes +429‎ ‎Changed an Item

7 June 2020

• curprev 05:1005:10, 7 June 2020‎ DG Regio talk contribs‎ 14,063 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 12:1412:14, 26 March 2020‎ DG Regio talk contribs‎ 13,632 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 09:1609:16, 4 March 2020‎ DG Regio talk contribs‎ 13,201 bytes +2,336‎ ‎Created claim: summary (P836): Reference_reference_projet:SA 42799 (2015/X):Commission Regulation (EC) No 651/2014, Article 18 Aid for consultancy in favour of SMEs, Implementation of the proposed project will enable the innovative biotech company Oncolarendi Therapeutics S.A. to obtain private capital effectively from institutional and individual investors in the context of the issue and placing on the public market in the main market of Securities Exchanges (GPW).The acquir...

18 February 2020

• curprev 07:4407:44, 18 February 2020‎ DG Regio talk contribs‎ 10,865 bytes +352‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 17:4917:49, 8 February 2020‎ DG Regio talk contribs‎ 10,513 bytes +823‎ ‎Changed an Item
• curprev 17:4917:49, 8 February 2020‎ DG Regio talk contribs‎ 9,690 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 10:2410:24, 31 January 2020‎ DG Regio talk contribs‎ 10,107 bytes +844‎ ‎Changed an Item

14 January 2020

• curprev 10:0910:09, 14 January 2020‎ DG Regio talk contribs‎ 9,263 bytes +9,263‎ ‎Created a new Item